reports
Shockwave Medical Reports First Quarter 2024 Financial Results
Shockwave Medical Reports First Quarter 2024 Financial Results SANTA CLARA, Calif., May 06, 2024 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (Nasdaq: SWAV), a pioneer in the development and commercialization of transformational technologies for the treatment of cardiovascular disease, today reported financial results for the three months ended March 31, 2024. “The solid growth in the first quarter across geographies and products is a testament to the continued demand for our innovative solutions, driven by the unrelenting and extraordinary performance of our global Shockwave teams,” said...
- Gary Brode
Shockwave Reducer Demonstrates Consistent, Positive Results in ‘Real-W...
Shockwave Reducer Demonstrates Consistent, Positive Results in ‘Real-World’ Study Six-Month Results from REDUCER-I Trial Add to Positive Evidence of the Coronary Sinus Reducer to Treat Refractory Angina SANTA CLARA, Calif., April 08, 2024 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development and commercialization of transformational technologies for the treatment of cardiovascular disease, today announced that investigators presented six-month data from the full population of the REDUCER-I study, alongside interim long-term follow-up results to three...
- Gary Brode
Shockwave Medical to Participate in the 23rd Annual Needham Virtual He...
Shockwave Medical to Participate in the 23rd Annual Needham Virtual Healthcare Conference SANTA CLARA, Calif., March 26, 2024 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (Nasdaq: SWAV), a pioneer in the development and commercialization of transformational technologies for the treatment of cardiovascular disease, announced today that the company will be participating in the 23rd Annual Needham Virtual Healthcare Conference, which is being held virtually from Monday, April 8 to Thursday, April 11, 2024. Shockwave’s management is scheduled for a live fireside chat on Tuesday, April 9, 20...
- Gary Brode
Shockwave Medical Reports Fourth Quarter and Full Year 2023 Financial ...
Shockwave Medical Reports Fourth Quarter and Full Year 2023 Financial Results SANTA CLARA, Calif., Feb. 15, 2024 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (Nasdaq: SWAV), a pioneer in the development and commercialization of transformational technologies for the treatment of cardiovascular disease, today reported financial results for the three months and full year ended December 31, 2023. Recent Highlights Recognized revenue of $203.0 million for the fourth quarter of 2023 and $730.2 million for the full year 2023, representing increases of 41% and 49%, respectively, from the sam...
- Gary Brode
- Gary Brode
Shockwave Medical Appoints Renee Gaeta as Chief Financial Officer
Shockwave Medical Appoints Renee Gaeta as Chief Financial Officer SANTA CLARA, Calif., Jan. 29, 2024 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development and commercialization of transformational technologies for the treatment of cardiovascular disease, announced today the appointment of Renee Gaeta as Chief Financial Officer (CFO), effective February 5, 2024. Renee succeeds Dan Puckett, CFO at Shockwave since 2016, who previously announced his decision to retire. “Renee is a highly skilled and accomplished executive with a proven track record in the m...
- Dave Nicoski
- Ross LaDuke
MTB M&T BANK CORPORATION
MASI MASIMO CORPORATION
SYY SYSCO CORPORATION
RGEN REPLIGEN CORPORATION
PZZA PAPA JOHN'S INTERNATIONAL INC.
PII POLARIS INC.
NFBK NORTHFIELD BANCORP INC.
MKTX MARKETAXESS HOLDINGS INC.
MCRI MONARCH CASINO & RESORT INC.
LANC LANCASTER COLONY CORPORATION
HRTX HERON THERAPEUTICS INC
FATE FATE THERAPEUTICS INC
EPC EDGEWELL PERSONAL CARE CO.
EIG EMPLOYERS HOLDINGS INC.
CFG CITIZENS FINANCIAL GROUP INC.
CBRL CRACKER BARREL OLD COUNTRY STORE INC.
BYD BOYD GAMING CORPORATION
ACCO ACCO BRANDS CORPORATION
UFCS UNITED FIRE GROUP INC.
CRI CARTER'S INC.
LNC LINCOLN NATIONAL CORPORATION
PRAA PRA GROUP INC.
BCBP BCB BANCORP INC.
STRO SUTRO BIOPHARMA
SWAV SHOCKWAVE MEDICAL
BSIG BRIGHTSPHERE INVESTMENT GROUP INC.
LC LENDINGCLUB CORP
RPRX ROYALTY PHARMA PLC CLASS A
CLPT CLEARPOINT NEURO INC
RTX RAYTHEON TECHNOLOGIES CORPORATION
AVIR ATEA PHARMACEUTICALS
CGEM CULLINAN ONCOLOGY INC
IPSC CENTURY THERAPEUTICS INC
ATXS ASTRIA THERAPEUTICS INC
WEST WESTROCK COFFEE COMPANY LLC
DOCS DOXIMITY INC
Shockwave Medical Provides Quarterly Earnings Release Dates for 2024
Shockwave Medical Provides Quarterly Earnings Release Dates for 2024 SANTA CLARA, Calif., Jan. 08, 2024 (GLOBE NEWSWIRE) -- January 8, 2024 – Shockwave Medical, Inc. (Nasdaq: SWAV), a pioneer in the development and commercialization of transformational technologies for the treatment of cardiovascular disease, announced today that it expects to issue quarterly earnings releases after the market closes and hold conference calls at the times indicated on the following dates: Fourth Quarter 2023 Earnings – Thursday, February 15, 2024 at 4:30 p.m. (ET)First Quarter 2024 Earnings – Monday, May...
Shockwave Medical to Participate in the 42nd Annual J.P. Morgan Health...
Shockwave Medical to Participate in the 42nd Annual J.P. Morgan Healthcare Conference SANTA CLARA, Calif., Dec. 20, 2023 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development and commercialization of transformational technologies for the treatment cardiovascular disease, announced today that the company will be participating in the 42nd Annual J.P. Morgan Healthcare Conference, which is being held from Monday, January 8 to Thursday, January 11, 2024, in San Francisco, CA. Shockwave management is scheduled for a live presentation on Wednesday, January ...
Shockwave Medical to Participate in the Piper Sandler 35th Annual Heal...
Shockwave Medical to Participate in the Piper Sandler 35th Annual Healthcare Conference SANTA CLARA, Calif., Nov. 15, 2023 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development and commercialization of transformational technologies for the treatment cardiovascular disease, announced today that the company will be participating in the Piper Sandler 35th Annual Healthcare Conference, which is being held from Tuesday, November 28 to Thursday, November 30, 2023 in New York, NY. Shockwave management is scheduled for a live fireside chat on Wednesday, Novembe...
New Shockwave Coronary IVL Publication Shows Similar Outcomes in Women...
New Shockwave Coronary IVL Publication Shows Similar Outcomes in Women And Men One-Year Outcomes Published in JSCAI Confirm Excellent, Consistent IVL Safety and Effectiveness Across Sexes SANTA CLARA, Calif., Nov. 09, 2023 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development and commercialization of transformational technologies for the treatment of cardiovascular disease, announced today new data demonstrating excellent one-year outcomes with coronary intravascular lithotripsy (IVL) that was consistent in both women and men. The one-year results from...
Shockwave Medical Reports Third Quarter 2023 Financial Results
Shockwave Medical Reports Third Quarter 2023 Financial Results SANTA CLARA, Calif., Nov. 06, 2023 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (Nasdaq: SWAV), a pioneer in the development and commercialization of transformational technologies for the treatment of cardiovascular disease, today reported financial results for the three months ended September 30, 2023. Recent Highlights Recognized revenue of $186.0 million for the third quarter of 2023, representing an increase of 42% from the same period in 2022Announced, priced and closed an offering for convertible debt, with net proceeds...
Centers for Medicare & Medicaid Services Establishes New Category I CP...
Centers for Medicare & Medicaid Services Establishes New Category I CPT® Add-On Code for Coronary IVL New Add-On Code Goes Into Effect January 1, 2024 SANTA CLARA, Calif., Nov. 03, 2023 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development and commercialization of transformational technologies for the treatment of cardiovascular disease, announced today that as part of the Calendar Year 2024 Physician Fee Schedule (PFS) final rule, the U.S. Centers for Medicare & Medicaid Services (CMS) has established a Category I Current Procedural Terminology (CPT®)...
Shockwave Medical Announces Details for Conference Call Discussing Thi...
Shockwave Medical Announces Details for Conference Call Discussing Third Quarter 2023 Results and Participation in Upcoming Investor Conference SANTA CLARA, Calif., Oct. 26, 2023 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development and commercialization of transformational technologies for the treatment cardiovascular disease, will report financial results for the third quarter 2023 after market close on Monday, November 6, 2023. Company management will host a corresponding conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time. O...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.